Regeneron and Sanofi declare plans to make Praluent more accessible for patients at high risk
In order to help ensure more affordable and timely access to patients whose medical needs are unmet , Regeneron Pharmaceuticals and Sanofi will offer payers that agree to lessen…
Read More...
Read More...
